{"id":"W4281653153","doi":"10.1200/jco.2022.40.16_suppl.e22019","title":"Naxitamab (NAX) treatment for refractory/relapsed (R/R) high-risk neuroblastoma (HR-NB): Response data and efficacy in patient (pt) subgroups.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Population; Phases of clinical research; Progressive disease; Gastroenterology; Clinical trial; Surgery; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00116067,0.0003582168,0.0008309781,0.000337833,0.0002245493,0.0004170462,0.0002931162,0.0004047584,0.003395883],"category_scores_gemma":[0.0006042626,0.0001354482,0.0005886593,0.0003618359,0.0003172525,0.0003905847,0.0002610108,0.0006011061,0.0005805704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005932308,"about_ca_system_score_gemma":0.0006496146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006510039,"about_ca_topic_score_gemma":0.001721026,"domain_scores_codex":[0.9996903,0.0001506783,0.00002587741,0.00004579945,0.00004050036,0.00004689619],"domain_scores_gemma":[0.9996215,0.00008518131,0.0001008686,0.00004032027,0.0000293372,0.0001228369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6172023,0.01287846,0.1050732,0.0009252433,0.001257223,0.0005025454,0.0003844872,0.002599075,0.04905736,0.0002791155,0.004075087,0.205766],"study_design_scores_gemma":[0.1106154,0.439255,0.4045657,0.0001343929,0.001642712,0.002783749,0.0002718376,0.00274782,0.0205359,0.0005492473,0.01684311,0.00005509585],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954572,0.001345984,0.0001707947,0.00007915484,0.00001221277,0.0004520187,0.001251123,0.00002311795,0.001208478],"genre_scores_gemma":[0.993409,0.0006183913,0.0005203969,0.0001442185,0.00002957372,0.0004026987,0.003479348,0.00001252014,0.001383726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003395883,"threshold_uncertainty_score":0.01136035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1283396375222562,"score_gpt":0.4588663981835789,"score_spread":0.3305267606613227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}